NPC appoints John O’Brien as president and CEO

April 2, 2021 by Chain Drug Review John O’Brien as president and chief executive officer, National Pharmaceutical Council (NPC) Leading Headlines, Pharmacy

WASHINGTON – The National Pharmaceutical Council (NPC) announced the appointment of veteran drug pricing and health policy expert John O’Brien, as president and chief executive officer. O’Brien, who will assume the role on June 1, will be responsible for overseeing NPC’s policy research and communications capacity, partnerships with other health care organizations, and strategic vision.